MENU
+Compare
ABT
Stock ticker: NYSE
AS OF
Dec 3, 04:59 PM (EDT)
Price
$125.29
Change
-$1.03 (-0.82%)
Capitalization
222.59B

ABT Abbott Laboratories Forecast, Technical & Fundamental Analysis

Abbott manufactures and markets cardiovascular and diabetes devices, adult and pediatric nutritional products, diagnostic equipment and testing kits, and branded generic drugs... Show more

ABT
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
a Summary for ABT with price predictions
Nov 28, 2025

ABT's RSI Oscillator ascending out of oversold territory

The RSI Oscillator for ABT moved out of oversold territory on November 04, 2025. This could be a sign that the stock is shifting from a downward trend to an upward trend. Traders may want to buy the stock or call options. The A.I.dvisor looked at 27 similar instances when the indicator left oversold territory. In of the 27 cases the stock moved higher. This puts the odds of a move higher at .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Moving Average Convergence Divergence (MACD) for ABT just turned positive on November 07, 2025. Looking at past instances where ABT's MACD turned positive, the stock continued to rise in of 55 cases over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where ABT advanced for three days, in of 315 cases, the price rose further within the following month. The odds of a continued upward trend are .

Bearish Trend Analysis

The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In of 58 cases where ABT's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are .

The Momentum Indicator moved below the 0 level on November 26, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on ABT as a result. In of 83 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

ABT moved below its 50-day moving average on November 17, 2025 date and that indicates a change from an upward trend to a downward trend.

The 50-day moving average for ABT moved below the 200-day moving average on November 14, 2025. This could be a long-term bearish signal for the stock as the stock shifts to an downward trend.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where ABT declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

ABT broke above its upper Bollinger Band on November 14, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

The Aroon Indicator for ABT entered a downward trend on November 12, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (4.369) is normal, around the industry mean (63.271). P/E Ratio (16.082) is within average values for comparable stocks, (37.178). Projected Growth (PEG Ratio) (2.271) is also within normal values, averaging (1.671). Dividend Yield (0.018) settles around the average of (0.018) among similar stocks. P/S Ratio (5.102) is also within normal values, averaging (35.282).

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. ABT’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 93, placing this stock slightly better than average.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

View a ticker or compare two or three
ABT
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I. Advisor
published Earnings

ABT is expected to report earnings to rise 15.38% to $1.50 per share on January 28

Abbott Laboratories ABT Stock Earnings Reports
Q4'25
Est.
$1.50
Q3'25
Est.
$1.30
Q2'25
Beat
by $0.01
Q1'25
Beat
by $0.02
Q4'24
Est.
$1.34
The last earnings report on October 15 showed earnings per share of $1.30, meeting the estimate of $1.30. With 1.65M shares outstanding, the current market capitalization sits at 222.59B.
A.I.Advisor
published Dividends

ABT paid dividends on November 17, 2025

Abbott Laboratories ABT Stock Dividends
А dividend of $0.59 per share was paid with a record date of November 17, 2025, and an ex-dividend date of October 15, 2025. Read more...
A.I. Advisor
published General Information

General Information

a manufacturer of health care products

Industry MedicalNursingServices

Profile
Fundamentals
Details
Industry
Medical Specialties
Address
100 Abbott Park Road
Phone
+1 224 667-6100
Employees
114000
Web
https://www.abbottinvestor.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
NATO35.770.36
+1.03%
Themes Transatlantic Defense ETF
TLT88.820.05
+0.06%
iShares 20+ Year Treasury Bond ETF
TBG33.58-0.06
-0.16%
TBG Dividend Focus ETF
FTXR36.81-0.10
-0.26%
First Trust Nasdaq Transportation ETF
PCN12.62-0.04
-0.32%
PIMCO Corporate & Income Strategy Fund

ABT and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, ABT has been loosely correlated with MDT. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if ABT jumps, then MDT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ABT
1D Price
Change %
ABT100%
-1.32%
MDT - ABT
48%
Loosely correlated
-1.24%
SYK - ABT
46%
Loosely correlated
-1.51%
STE - ABT
44%
Loosely correlated
-1.33%
BAX - ABT
43%
Loosely correlated
-1.26%
ALC - ABT
41%
Loosely correlated
+1.29%
More

Groups containing ABT

Correlation & Price change

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ABT
1D Price
Change %
ABT100%
-1.32%
Medical/Nursing Services
industry (214 stocks)
32%
Poorly correlated
+1.25%
Health Services
industry (421 stocks)
-1%
Poorly correlated
+0.70%